403.4000 -10.40 (-2.51%)
NSE Aug 28, 2026 15:31 PM
Volume: 293.1K
 

403.40
-2.51%
Angel Broking
Unique investment opportunity in drug research business: While almost all Indian pharma companies are in generic drugs business, Syngene supports its clients to invent new drugs. It has 8 of the top 10 global pharma companies as its clients and also has long term contracts with some big pharma companies. In our view Syngene provides a uni..
Syngene Intl has lost -35.55% in the last 1 Year
More from Syngene International Ltd.
Recommended